Clinical Trial Update: Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating lot-to-lot consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and comparing safety and immunogenicity to Menactra in healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))
• SIIPL Meningococcal ACYWX Conjugate Vaccine (Meningococcal ACYWX conjugate vaccine)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Vaccine for Meningococcal Disease | Phase 2, Phase 3 | Status: COMPLETED